IRIS Accounts Production v25.1.0.734 06366199 director 29.2.24 1.3.23 29.2.24 29.2.24 the provision of quality care home facilities from five homes in the East Riding of Yorkshire and North Yorkshire. true true true false true true false false false false true false Ordinary 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh063661992023-02-28063661992024-02-29063661992023-03-012024-02-29063661992022-02-28063661992022-03-012023-02-28063661992023-02-2806366199ns15:EnglandWales2023-03-012024-02-2906366199ns14:PoundSterling2023-03-012024-02-2906366199ns10:Director12023-03-012024-02-2906366199ns10:Consolidated2024-02-2906366199ns10:ConsolidatedGroupCompanyAccounts2023-03-012024-02-2906366199ns10:PrivateLimitedCompanyLtd2023-03-012024-02-2906366199ns10:Consolidatedns10:FRS1022023-03-012024-02-2906366199ns10:Consolidatedns10:Audited2023-03-012024-02-2906366199ns10:LargeMedium-sizedCompaniesRegimeForDirectorsReport2023-03-012024-02-2906366199ns10:LargeMedium-sizedCompaniesRegimeForAccounts2023-03-012024-02-2906366199ns10:Consolidatedns10:LargeMedium-sizedCompaniesRegimeForDirectorsReport2023-03-012024-02-2906366199ns10:LargeMedium-sizedCompaniesRegimeForAccountsns10:Consolidated2023-03-012024-02-2906366199ns10:FullAccounts2023-03-012024-02-2906366199ns5:Subsidiary12023-03-012024-02-290636619912023-03-012024-02-2906366199ns10:OrdinaryShareClass12023-03-012024-02-2906366199ns10:Consolidated2023-03-012024-02-2906366199ns10:RegisteredOffice2023-03-012024-02-2906366199ns10:Consolidated2022-03-012023-02-2806366199ns5:CurrentFinancialInstruments2024-02-2906366199ns5:CurrentFinancialInstruments2023-02-2806366199ns5:Non-currentFinancialInstruments2024-02-2906366199ns5:Non-currentFinancialInstruments2023-02-2806366199ns5:ShareCapital2024-02-2906366199ns5:ShareCapital2023-02-2806366199ns5:RetainedEarningsAccumulatedLosses2024-02-2906366199ns5:RetainedEarningsAccumulatedLosses2023-02-2806366199ns5:ShareCapital2022-02-2806366199ns5:RetainedEarningsAccumulatedLosses2022-02-2806366199ns5:RetainedEarningsAccumulatedLosses2022-03-012023-02-2806366199ns5:RetainedEarningsAccumulatedLosses2023-03-012024-02-2906366199ns5:IntangibleAssetsOtherThanGoodwill2023-03-012024-02-2906366199ns5:OwnedOrFreeholdAssetsns5:LandBuildings2023-03-012024-02-2906366199ns5:FurnitureFittings2023-03-012024-02-2906366199ns5:MotorVehicles2023-03-012024-02-2906366199ns5:ComputerEquipment2023-03-012024-02-2906366199ns5:FurnitureFittings2023-02-2806366199ns5:MotorVehicles2023-02-2806366199ns5:ComputerEquipment2023-02-2806366199ns5:FurnitureFittings2024-02-2906366199ns5:MotorVehicles2024-02-2906366199ns5:ComputerEquipment2024-02-2906366199ns5:FurnitureFittings2023-02-2806366199ns5:MotorVehicles2023-02-2806366199ns5:ComputerEquipment2023-02-2806366199ns5:CostValuation2023-02-2806366199ns5:Subsidiary112023-03-012024-02-2906366199ns5:Subsidiary12024-02-2906366199ns5:Subsidiary12023-02-2806366199ns5:Subsidiary12022-03-012023-02-2806366199ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-02-2906366199ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-02-2806366199ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2024-02-2906366199ns5:Non-currentFinancialInstrumentsns5:BetweenOneTwoYears2023-02-2806366199ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-02-2906366199ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-02-2806366199ns5:Secured2024-02-2906366199ns5:Secured2023-02-2806366199ns5:DeferredTaxation2023-02-2806366199ns5:DeferredTaxation2023-03-012024-02-2906366199ns5:DeferredTaxation2024-02-2906366199ns10:OrdinaryShareClass12024-02-2906366199ns5:RetainedEarningsAccumulatedLosses2023-02-28
REGISTERED NUMBER: 06366199 (England and Wales)
























GROUP STRATEGIC REPORT,

REPORT OF THE DIRECTOR AND

CONSOLIDATED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 29 FEBRUARY 2024

FOR

SABRINA HEALTH CARE LIMITED

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

CONTENTS OF THE CONSOLIDATED FINANCIAL STATEMENTS
For The Year Ended 29 February 2024










Page

Company Information 1

Group Strategic Report 2

Report of the Director 3

Report of the Independent Auditors 5

Consolidated Statement of Comprehensive Income 8

Consolidated Balance Sheet 9

Company Balance Sheet 10

Consolidated Statement of Changes in Equity 11

Company Statement of Changes in Equity 12

Consolidated Cash Flow Statement 13

Notes to the Consolidated Cash Flow Statement 14

Notes to the Consolidated Financial Statements 15


SABRINA HEALTH CARE LIMITED

COMPANY INFORMATION
For The Year Ended 29 February 2024







DIRECTOR: Mr T Seeneevassen





REGISTERED OFFICE: 5&6 Manor Court
Manor Garth
Scarborough
North Yorkshire
YO11 3TU





REGISTERED NUMBER: 06366199 (England and Wales)





AUDITORS: Fortus Audit LLP
Chartered Accountants & Statutory Auditors
5 & 6 Manor Garth
Manor Court
Scarborough
North Yorkshire
YO11 3TU

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

GROUP STRATEGIC REPORT
For The Year Ended 29 February 2024


The director presents his strategic report of the company and the group for the year ended 29 February 2024.

REVIEW OF BUSINESS
The group's profit for the year, before interest, tax and depreciation, amounted to £1,469,279 (2023 - £847,405).

The director is committed to meeting the challenge of operating within the care industry and the regular changes in regulations that come with it.

PRINCIPAL RISKS AND UNCERTAINTIES
The group operates in a competitive industry with a wide choice of care options available to potential clients. The director makes full use of his extensive knowledge and experience of the sector to ensure that the group is well placed to attract new clients for its five care homes.

The East Coast continues to be an attractive location for retirement and this along with an ageing population should ensure that demand will remain high for care in the area in the future.

Changes in policies in respect of the standards of care required could have an impact on the business, but the director is committed to meeting and advancing the current standards required by the Care Quality Commission and keeping ahead of future developments.

KEY PERFORMANCE INDICATORS
The director considers that turnover, profit before interest, tax and depreciation and occupancy levels are the key performance indicators which are necessary to give an understanding of the development and performance of the business.

Turnover increased significantly on the previous years, reflecting increased occupancy levels at the homes, following continued investment on the properties to maintain standards of care. Staff costs increased as the business continues to grow and invest in a long term staffing programme, though still relies on a bank of agency workers. As mentioned above, the business also invested heavily in the homes by way of a continual repairs and maintenance programme.

Summary of KPI's 2024 2023 2022

Turnover 6,028,679 4,810,676 4,147,214
Profit before interest, tax and
depreciation

1,469,279

847,405

427,731

ON BEHALF OF THE BOARD:





Mr T Seeneevassen - Director


25 April 2025

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

REPORT OF THE DIRECTOR
For The Year Ended 29 February 2024


The director presents his report with the financial statements of the company and the group for the year ended 29 February 2024.

DIVIDENDS
An interim dividend of 250 per share was paid on 23 February 2024. The director recommends that no final dividend be paid.

The total distribution of dividends for the year ended 29 February 2024 will be £ 25,000 .

DIRECTOR
Mr T Seeneevassen held office during the whole of the period from 1 March 2023 to the date of this report.

MATTERS COVERED IN THE STRATEGIC REPORT
Disclosures required under S416(4) of the Companies Act 2006 are commented upon in the Strategic Report as the directors consider them to be of strategic importance to the company. This includes consideration of the future developments of the company.

STATEMENT OF DIRECTOR'S RESPONSIBILITIES
The director is responsible for preparing the Group Strategic Report, the Report of the Director and the financial statements in accordance with applicable law and regulations.

Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the director must not approve the financial statements unless he is satisfied that they give a true and fair view of the state of affairs of the company and the group and of the profit or loss of the group for that period. In preparing these financial statements, the director is required to:

- select suitable accounting policies and then apply them consistently;
- make judgements and accounting estimates that are reasonable and prudent;
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company's and the group's transactions and disclose with reasonable accuracy at any time the financial position of the company and the group and enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the company and the group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the director is aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the group's auditors are unaware, and he has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the group's auditors are aware of that information.

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

REPORT OF THE DIRECTOR
For The Year Ended 29 February 2024


AUDITORS
The auditors, Fortus Audit LLP, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:



Mr T Seeneevassen - Director


25 April 2025

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
SABRINA HEALTH CARE LIMITED


Disclaimer of opinion

We were engaged to audit the financial statements of Sabrina Health Care Limited (the 'parent company') and its subsidiaries ('the group') for the year ended 29 February 2024 which comprise the Consolidated Statement of Comprehensive Income, Consolidated Balance Sheet, Company Balance Sheet, Consolidated Statement of Changes in Equity, Company Statement of Changes in Equity, Consolidated Cash Flow Statement and Notes to the Consolidated Cash Flow Statements, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard FRS102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

We do not express an opinion on the accompanying financial statements of the company. Because of the significance of the matter described in the basis for disclaimer of opinion section of our report, we have not been able to obtain sufficient appropriate audit evidence to provide a basis for an audit opinion on these financial statements.

Basis for disclaimer of opinion
During the course of our audit work management were unable to provide us with:

- documentary evidence over a representative sample of expenditure. We were therefore unable to the conclude on the validity of cost of sales and administrative expenses in the accounts amounting to £1,117,331.

- documentary evidence over a representative sample residents income. We were therefore unable to conclude on the accuracy and completeness of turnover amounting to £6,028,679.

- documentary evidence over the existence of employees and documentary evidence over the rates of pay of employees. We were therefore unable to conclude on the existence and accuracy of wages costs amounting to £3,174,744.

As a result of these matters, we were unable to determine whether any adjustments might have been found necessary in respect of turnover, costs and wages, trade debtors and trade creditors, and the elements making up the statement of comprehensive income, statement of changes in equity and statement of cash flows.

.

Other information
The director is responsible for the other information. The other information comprises the information in the Group Strategic Report and the Report of the Director, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
SABRINA HEALTH CARE LIMITED


Opinions on other matters prescribed by the Companies Act 2006
Because of the significance of the matter described in the basis for disclaimer of opinion section of our report, we have been unable to form an opinion, whether based on the work undertaken in the course of the audit:

- the information given in the strategic report and directors' report for the financial year for which the financial statements are prepared is inconsistent with the financial statements; and
- the strategic report and directors' report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Report of the Director.

Notwithstanding our disclaimer of an opinion on the financial statements, in the light of the knowledge and understanding of the company and its environment obtained in the course of the audit performed subject to the pervasive limitation described above, we have not identified material misstatements in the strategic report of the directors report.

Arising from the limitation of our work referred to above:

- we have not obtained all the information and explanations that we considered necessary for the purpose of our audit; and
- we were unable to determine whether adequate accounting records have been kept.

- returns adequate for our audit have not been received from branches not visited by us; or
- the parent company financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of director's remuneration specified by law are not made.

Responsibilities of director
As explained more fully in the Statement of Director's Responsibilities set out on page three, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the director is responsible for assessing the group's and the parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the group or the parent company or to cease operations, or has no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our responsibility is to conduct an audit of the company's and group's financial statements in accordance with International Standards on Auditing (UK) and to issue an auditor's report.

However, because of the matter described in the basis for disclaimer of opinion section of our report, we were not able to obtain sufficient appropriate audit evidence to provide a basis for an audit opinion on these financial statements.

We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
SABRINA HEALTH CARE LIMITED


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Frances Howard FCA (Senior Statutory Auditor)
for and on behalf of Fortus Audit LLP
Chartered Accountants & Statutory Auditors
5 & 6 Manor Garth
Manor Court
Scarborough
North Yorkshire
YO11 3TU

25 April 2025

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

CONSOLIDATED
STATEMENT OF COMPREHENSIVE
INCOME
For The Year Ended 29 February 2024

2024 2023
Notes £    £   

TURNOVER 6,028,679 4,810,676

Cost of sales 3,580,091 3,172,381
GROSS PROFIT 2,448,588 1,638,295

Administrative expenses 1,188,978 1,019,101
1,259,610 619,194

Other operating income - 16,610
OPERATING PROFIT 4 1,259,610 635,804


Interest payable and similar expenses 5 149,647 127,472
PROFIT BEFORE TAXATION 1,109,963 508,332

Tax on profit 6 288,871 192,102
PROFIT FOR THE FINANCIAL YEAR 821,092 316,230

OTHER COMPREHENSIVE INCOME - -
TOTAL COMPREHENSIVE INCOME FOR THE
YEAR

821,092

316,230

Profit attributable to:
Owners of the parent 821,092 316,230

Total comprehensive income attributable to:
Owners of the parent 821,092 316,230

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

CONSOLIDATED BALANCE SHEET
29 February 2024

2024 2023
Notes £    £    £   
FIXED ASSETS
Intangible assets 9 235,997 294,995
Tangible assets 10 5,543,327 5,692,598
Investments 11 - -
5,779,324 5,987,593

CURRENT ASSETS
Stocks 12 1,500 1,500
Debtors 13 487,545 240,440
Cash at bank 318,634 142,366
807,679 384,306
CREDITORS
Amounts falling due within one year 14 1,492,314 935,516
NET CURRENT LIABILITIES (684,635 ) (551,210 )
TOTAL ASSETS LESS CURRENT LIABILITIES 5,094,689 5,436,383

CREDITORS
Amounts falling due after more than
one year

15

(1,163,799

)

(2,264,793

)

PROVISIONS FOR LIABILITIES 18 (322,389 ) (359,181 )
NET ASSETS 3,608,501 2,812,409

CAPITAL AND RESERVES
Called up share capital 19 100 100
Revaluation reserve 20 811,565 856,237
Retained earnings 20 2,796,836 1,956,072
SHAREHOLDERS' FUNDS 3,608,501 2,812,409

The financial statements were approved by the director and authorised for issue on 25 April 2025 and were signed by:





Mr T Seeneevassen - Director


SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

COMPANY BALANCE SHEET
29 February 2024

2024 2023
Notes £    £    £   
FIXED ASSETS
Intangible assets 9 - -
Tangible assets 10 65,199 75,869
Investments 11 3,040,944 3,040,944
3,106,143 3,116,813

CURRENT ASSETS
Stocks 12 1,500 1,500
Debtors 13 487,545 3,118,741
Cash at bank 318,634 142,366
807,679 3,262,607
CREDITORS
Amounts falling due within one year 14 1,492,314 935,516
NET CURRENT (LIABILITIES)/ASSETS (684,635 ) 2,327,091
TOTAL ASSETS LESS CURRENT LIABILITIES 2,421,508 5,443,904

CREDITORS
Amounts falling due after more than
one year

15

(1,163,799

)

(2,264,793

)

PROVISIONS FOR LIABILITIES 18 (16,300 ) (18,967 )
NET ASSETS 1,241,409 3,160,144

CAPITAL AND RESERVES
Called up share capital 19 100 100
Retained earnings 20 1,241,309 3,160,044
SHAREHOLDERS' FUNDS 1,241,409 3,160,144

Company's (loss)/profit for the financial
year

(1,893,735

)

569,545

The financial statements were approved by the director and authorised for issue on 25 April 2025 and were signed by:





Mr T Seeneevassen - Director


SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
For The Year Ended 29 February 2024

Called up
share Retained Revaluation Total
capital earnings reserve equity
£    £    £    £   
Balance at 1 March 2022 100 1,507,329 990,750 2,498,179

Changes in equity
Dividends - (2,000 ) - (2,000 )
Total comprehensive income - 450,743 (134,513 ) 316,230
Balance at 28 February 2023 100 1,956,072 856,237 2,812,409

Changes in equity
Dividends - (25,000 ) - (25,000 )
Total comprehensive income - 865,764 (44,672 ) 821,092
Balance at 29 February 2024 100 2,796,836 811,565 3,608,501

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

COMPANY STATEMENT OF CHANGES IN EQUITY
For The Year Ended 29 February 2024

Called up
share Retained Total
capital earnings equity
£    £    £   
Balance at 1 March 2022 100 2,592,499 2,592,599

Changes in equity
Dividends - (2,000 ) (2,000 )
Total comprehensive income - 569,545 569,545
Balance at 28 February 2023 100 3,160,044 3,160,144

Changes in equity
Dividends - (25,000 ) (25,000 )
Total comprehensive income - (1,893,735 ) (1,893,735 )
Balance at 29 February 2024 100 1,241,309 1,241,409

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

CONSOLIDATED CASH FLOW STATEMENT
For The Year Ended 29 February 2024

2024 2023
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 1,630,471 885,318
Interest paid (149,647 ) (127,472 )
Tax paid (10,902 ) (91,581 )
Net cash from operating activities 1,469,922 666,265

Cash flows from investing activities
Purchase of tangible fixed assets (1,399 ) (8,161 )
Net cash from investing activities (1,399 ) (8,161 )

Cash flows from financing activities
Bank loan repayments in year (1,140,551 ) (672,219 )
Amount introduced by directors 423,685 615,412
Amounts withdrawn by directors (550,389 ) (508,616 )
Equity dividends paid (25,000 ) (2,000 )
Net cash from financing activities (1,292,255 ) (567,423 )

Increase in cash and cash equivalents 176,268 90,681
Cash and cash equivalents at beginning
of year

2

142,366

51,685

Cash and cash equivalents at end of
year

2

318,634

142,366

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED CASH FLOW STATEMENT
For The Year Ended 29 February 2024


1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

2024 2023
£    £   
Profit before taxation 1,109,963 508,332
Depreciation charges 209,668 211,601
Finance costs 149,647 127,472
1,469,278 847,405
Increase in trade and other debtors (120,401 ) (86,491 )
Increase in trade and other creditors 281,594 124,404
Cash generated from operations 1,630,471 885,318

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 29 February 2024
29.2.24 1.3.23
£    £   
Cash and cash equivalents 318,634 142,366
Year ended 28 February 2023
28.2.23 1.3.22
£    £   
Cash and cash equivalents 142,366 51,685


3. ANALYSIS OF CHANGES IN NET DEBT

At 1.3.23 Cash flow At 29.2.24
£    £    £   
Net cash
Cash at bank 142,366 176,268 318,634
142,366 176,268 318,634
Debt
Debts falling due within 1 year (397,011 ) 39,557 (357,454 )
Debts falling due after 1 year (2,264,793 ) 1,100,994 (1,163,799 )
(2,661,804 ) 1,140,551 (1,521,253 )
Total (2,519,438 ) 1,316,819 (1,202,619 )

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
For The Year Ended 29 February 2024


1. STATUTORY INFORMATION

Sabrina Health Care Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the General Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Financial Reporting Standard 102 - reduced disclosure exemptions
In preparing the financial statements of the parent company, advantage has been taken of the following disclosure exemptions under FRS 102:

- No cash flow statement has been prepared for the parent company.
- No disclosure has been given for the aggregate remuneration of the key management
personnel of the parent company, as their remuneration is included in the total for the group
as a whole.

Basis of consolidation
The consolidated accounts incorporate the accounts of Sabrina Health Care Limited and its subsidiary and all figures used relate to the year ended 29 February 2024.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is derived from care home fees and all arises from activities carried on in the United Kingdom.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Goodwill arising on the acquisition of the subsidiary is being amortised over 20 years on a straight line basis.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - 12% on reducing balance
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 20% on reducing balance
Computer equipment - 20% on cost

Stocks
Stocks relate to food and medical provisions in the homes and are valued at cost.


SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 29 February 2024


2. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Consolidated Statement of Comprehensive Income, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The group operates a defined contribution pension scheme. Contributions payable to the group's pension scheme are charged to profit or loss in the period to which they relate.

Going concern
The director has considered the impact of rising energy costs and minimum wage increases in relation to their assessment of going concern and in their opinion have taken all reasonable steps to mitigate these factors. As at the point of authorising the accounts, and for the foreseeable future, the director considers the going concern assumption to still be appropriate. The director acknowledges that given the currently rapidly changing business and social environment, there are likely to be significant unknown factors which may present themselves. Such factors are considered by the director to represent a general inherent level of risk in relation to the going concern assumption albeit not quantifiable at this time

The director has a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future. Thus he continues to adopt the going concern basis of accounting in preparing the financial statements.

Government grants
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the company will comply with conditions attaching to them and the grants will be received using the accrual model.

Debtors and creditors receivable / payable within one year
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 29 February 2024


3. EMPLOYEES AND DIRECTORS
2024 2023
£    £   
Wages and salaries 2,899,810 2,536,406
Social security costs 234,786 208,823
Other pension costs 40,148 39,242
3,174,744 2,784,471

The average number of employees during the year was as follows:
2024 2023

Directors 1 1
Administration and management 1 2
Nursing and kitchen 140 128
142 131

2024 2023
£    £   
Director's remuneration 23,000 24,000

Key management personnel is considered to be the director of the company.

4. OPERATING PROFIT

The operating profit is stated after charging:

2024 2023
£    £   
Hire of plant and machinery 2,421 2,246
Depreciation - owned assets 150,670 152,603
Goodwill amortisation 58,998 58,998
Auditors' remuneration 12,000 9,684
Auditors' remuneration for non audit work 22,424 11,032

5. INTEREST PAYABLE AND SIMILAR EXPENSES
2024 2023
£    £   
Bank loan interest 142,861 126,176
Other interest 6,786 1,296
149,647 127,472

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 29 February 2024


6. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2024 2023
£    £   
Current tax:
UK corporation tax 325,663 132,944

Deferred tax (36,792 ) 59,158
Tax on profit 288,871 192,102

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2024 2023
£    £   
Profit before tax 1,109,963 508,332
Profit multiplied by the standard rate of corporation tax in the UK
of 25 % (2023 - 19 %)

277,491

96,583

Effects of:
Expenses not deductible for tax purposes 50 -
Capital allowances in excess of depreciation - (5,099 )
Depreciation in excess of capital allowances 17,988 -
Deferred tax due to increase in tax rate - 100,618
Adjustment for change of tax rate in the year (6,658 ) -
Total tax charge 288,871 192,102

7. INDIVIDUAL STATEMENT OF COMPREHENSIVE INCOME

As permitted by Section 408 of the Companies Act 2006, the Statement of Comprehensive Income of the parent company is not presented as part of these financial statements.


8. DIVIDENDS
2024 2023
£    £   
Ordinary shares of 1 each
Interim 25,000 2,000

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 29 February 2024


9. INTANGIBLE FIXED ASSETS

Group
Goodwill
£   
COST
At 1 March 2023 1,273,882
Disposals (96,250 )
At 29 February 2024 1,177,632
AMORTISATION
At 1 March 2023 978,887
Amortisation for year 58,998
Eliminated on disposal (96,250 )
At 29 February 2024 941,635
NET BOOK VALUE
At 29 February 2024 235,997
At 28 February 2023 294,995

10. TANGIBLE FIXED ASSETS

Group
Fixtures
Freehold and Motor Computer
property fittings vehicles equipment Totals
£    £    £    £    £   
COST
At 1 March 2023 6,825,135 393,737 18,450 2,509 7,239,831
Additions - - - 1,399 1,399
At 29 February 2024 6,825,135 393,737 18,450 3,908 7,241,230
DEPRECIATION
At 1 March 2023 1,220,294 312,085 13,676 1,178 1,547,233
Charge for year 136,502 12,561 954 653 150,670
At 29 February 2024 1,356,796 324,646 14,630 1,831 1,697,903
NET BOOK VALUE
At 29 February 2024 5,468,339 69,091 3,820 2,077 5,543,327
At 28 February 2023 5,604,841 81,652 4,774 1,331 5,692,598

All of the properties were last revalued on the 25th November 2014 by Edward Symmons LLP independent chartered surveyors. Upon transition to FRS102, this was taken to be deemed cost.

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 29 February 2024


10. TANGIBLE FIXED ASSETS - continued

Company
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 March 2023 175,123 18,450 2,509 196,082
Additions - - 1,399 1,399
At 29 February 2024 175,123 18,450 3,908 197,481
DEPRECIATION
At 1 March 2023 105,359 13,676 1,178 120,213
Charge for year 10,462 954 653 12,069
At 29 February 2024 115,821 14,630 1,831 132,282
NET BOOK VALUE
At 29 February 2024 59,302 3,820 2,077 65,199
At 28 February 2023 69,764 4,774 1,331 75,869

11. FIXED ASSET INVESTMENTS

Company
Shares in
group
undertakings
£   
COST
At 1 March 2023
and 29 February 2024 3,040,944
NET BOOK VALUE
At 29 February 2024 3,040,944
At 28 February 2023 3,040,944

The group or the company's investments at the Balance Sheet date in the share capital of companies include the following:

Subsidiary

Hexon Limited
Registered office: 5&6 Manor Court, Manor Garth, Scarborough, YO11 3TU.
Nature of business: Non trading
%
Class of shares: holding
Ordinary 100.00
2024 2023
£    £   
Aggregate capital and reserves 5,172,039 2,398,214
Profit/(loss) for the year 2,773,825 (194,317 )


SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 29 February 2024


12. STOCKS

Group Company
2024 2023 2024 2023
£    £    £    £   
Stocks 1,500 1,500 1,500 1,500

13. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2024 2023 2024 2023
£    £    £    £   
Trade debtors 319,155 188,875 319,155 188,875
Amounts owed by group undertakings - - - 2,878,301
Amounts owed by related parties 11,687 21,566 11,687 21,566
Director' loan account 156,703 29,999 156,703 29,999
487,545 240,440 487,545 3,118,741

14. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

Group Company
2024 2023 2024 2023
£    £    £    £   
Bank loans and overdrafts (see note 16) 357,454 397,011 357,454 397,011
Deferred income 129,624 128,054 129,624 128,054
Trade creditors 74,316 15,134 74,316 15,134
Corporation tax 465,451 150,690 465,451 150,690
Social security and other taxes 61,889 39,427 61,889 39,427
Other creditors 348,424 185,711 348,424 185,711
Accrued expenses 55,156 19,489 55,156 19,489
1,492,314 935,516 1,492,314 935,516

15. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

Group Company
2024 2023 2024 2023
£    £    £    £   
Bank loans (see note 16) 1,163,799 2,264,793 1,163,799 2,264,793

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 29 February 2024


16. LOANS

An analysis of the maturity of loans is given below:

Group Company
2024 2023 2024 2023
£    £    £    £   
Amounts falling due within one year or on demand:
Bank loans 357,454 397,011 357,454 397,011
Amounts falling due between one and two years:
Bank loans 382,454 382,454 382,454 382,454
Amounts falling due between two and five years:
Bank loans 781,345 1,208,960 781,345 1,208,960
Amounts falling due in more than five years:
Repayable by instalments
Bank loans - 673,379 - 673,379

The loan repayment terms are monthly instalments and the interest rate is charged at 1.95% above base rate.

17. SECURED DEBTS

The following secured debts are included within creditors:

Company
2024 2023
£    £   
Bank loans 1,521,253 2,661,804

The company has given as security a first legal charge over the groups freehold land and buildings.

18. PROVISIONS FOR LIABILITIES

Group Company
2024 2023 2024 2023
£    £    £    £   
Deferred tax 322,389 359,181 16,300 18,967

Group
Deferred
tax
£   
Balance at 1 March 2023 359,181
Unused amounts reversed during year (36,792 )
Balance at 29 February 2024 322,389

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 29 February 2024


18. PROVISIONS FOR LIABILITIES - continued

Company
Deferred
tax
£   
Balance at 1 March 2023 18,967
Unused amounts reversed during year (2,667 )
Balance at 29 February 2024 16,300

19. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
100 Ordinary 1 100 100

20. RESERVES

Group
Retained Revaluation
earnings reserve Totals
£    £    £   

At 1 March 2023 1,956,072 856,237 2,812,309
Profit for the year 821,092 821,092
Dividends (25,000 ) (25,000 )
Deferred tax adjustment (34,125 ) 34,125 -
Depreciation movement 78,797 (78,797 ) -
At 29 February 2024 2,796,836 811,565 3,608,401

Company
Retained
earnings
£   

At 1 March 2023 3,160,044
Deficit for the year (1,893,735 )
Dividends (25,000 )
At 29 February 2024 1,241,309


21. PENSION COMMITMENTS

The group operates a work place defined contribution pension scheme for the benefit of employees who have opted in. The assets of the scheme are administered by trustees in a fund independent from those of the group. The total contributions paid in the year amounted to £40,148 (2023 - £39,242).

SABRINA HEALTH CARE LIMITED (REGISTERED NUMBER: 06366199)

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS - continued
For The Year Ended 29 February 2024


22. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 29 February 2024 and 28 February 2023:

2024 2023
£    £   
Mr T Seeneevassen
Balance outstanding at start of year 29,999 136,795
Amounts advanced 601,613 376,265
Amounts repaid (474,909 ) (483,061 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 156,703 29,999

No interest is accruing on the directors loan account.

23. RELATED PARTY DISCLOSURES

Hexon Limited has provided assets as security against the parent company's borrowing.

Debtors includes a loan of £11,687 (2023 - £21,566) to a related company, Aalia Health Care Limited, a company under common control.

During the year, the group paid rent of £24,000 (2023 - £24,000) to the director for the use of head office premises.

24. ULTIMATE CONTROLLING PARTY

The group is controlled by its sole director, Mr T Seeneevassen, who owns 100% of the share capital.